Modular Medical announces first human use of MODD1 pump

Modular Medical (MODD) announced the first human use of the MODD1 pump to deliver insulin to a person with diabetes in a real-world setting. The MODD1 is delivering insulin to a clinician with Type 1 under institutional review board approval from the United States Food and Drug Administration, which is necessary because the reusable controller line is being validated for human use. Modular Medical intends to deploy its insulin units on multiple clinicians at multiple sites in a trial in the middle of August and looks forward to updating the market further on future developments.